Seres Therapeutics, Inc. MCRB

US Biotechnology

$1.64 ▼ -3.53% ($-0.06)

🧊 52W Low ⬇️ Below Yest. Low 🎈 Low Float

Open $1.69

Prev Close $1.70

Day Range $1.57 – $1.74

52W Range $1.68 – $29.98

Market Cap $17.33M

P/E (TTM) 3.29

Beta 0.62

EPS (TTM) $-2.33

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2015-06-26
Shares Out.	9,940,000
Website	serestherapeutics.com ↗
Phone	16179459626
Employees	66
Revenue	$593,000
Gross Profit	$593,000
Net Income	-$16.3M
Free Cash Flow	-$64.0M
Total Assets	$65.9M
Total Liabilities	$44.5M
Equity	$21.4M

About Seres Therapeutics, Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Seres Therapeutics, Inc. is a publicly traded company under the ticker symbol MCRB on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.